Categories: Research

“UCSF has put its stake in the ground on exposing industry manipulation of science.”

A tiny implant promises to simplify how glaucoma drugs are administered, making life easier for aging patients.

A pioneering public/private consortium is poised to turn the marathon of drug discovery into a team relay, maybe even a short one.

For decades, scientists have wanted to be able to study dopamine receptors one by one. The brain’s dopamine receptors are responsible for a variety of behaviors, such as reward seeking, and are also involved in psychiatric illnesses like schizophrenia.

A UC San Francisco-created, insulin-generating implant that utilizes nanotechnology is closer to becoming a real treatment for diabetes, after being acquired by a San Francisco-based startup.

Kidney failure is a debilitating and ultimately deadly illness, and a health policy crisis. With 468,000 people on dialysis in the U.S., costing the government $31 billion dollars a year, very little money is spent on researching alternatives to current treatments.

Strategic plan progress report. Research: Driving the development of innovative and precise drugs, medical devices, and diagnostic tests.

The common lab practice of adding antibiotics to cell cultures to prevent contamination can actually induce genetic changes in the cells, a paper senior-authored by Nadav Ahituv, PhD, found. Ahituv is a faculty member in the Department of Bioengineering and Therapeutic Sciences, a joint department...

Many of the medicines we depend on to treat disease—and even to save our lives—pose potentially serious risks along with their benefits. Data from the U.S. Centers for Disease Control and Prevention indicate that about 40,000 deaths yearly in the United States may be attributable to the side...

Charles S. Craik, PhD, joins the 237th class of newly elected members of the prestigious American Academy of Arts and Sciences who will be inducted on October 7, 2017 at a ceremony in Cambridge, Massachusetts.